Douglas Carl Behenna,Ping Chen,Kevin Daniel Freeman-Cook,Robert Louis Hoffman,Mehran Jalaie,Asako Nagata,Sajiv Krishnan Nair,Sacha Ninkovic,Martha Alicia Ornelas,Cynthia Louise Palmer,Eugene Yuanjin R
申请号：
US16251032
公开号：
US10800783B2
申请日:
2019.01.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This invention relates to compounds of general Formula (I)and pharmaceutically acceptable salts thereof, in which R1, R2, R2A, R2B, R3, R4, R5A, R5B, R6, R7, R8, R9, p, q and r are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
